May 8, 2026
Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator focused on making fertility and non-surgical permanent birth control more accessible and cost-effective for women worldwide, announced today an update related to: Femasys Announces Financial Results for Quarter Ended March 31, 2026 and Provides Corporate Update.
